EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial

Matthew J Belanger iD, Lara C Kovell iD, Ruth-Alma Turkson-Ocran iD, Kenneth J Mukamal iD, Xiaoran Liu iD, Lawrence J Appel iD, Edgar R Miller iD, Frank M Sacks iD, Robert H Christenson iD, Heather Rebuck, Alex R Chang iD, Stephen P Juraschek iD

Journal of the American Heart Association · 17.01.2023 · 12 (2)

DOI: 10.1161/jaha.122.026684 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 17.01.2023. Verfasst von Matthew J Belanger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine Johns Hopkins Medical Institutions Baltimore MD. Hauptthemen laut MEDLINE: Dietary Approaches To Stop Hypertension, Hypertension. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Dietary Approaches to Stop Hypertension (DASH) diet has been shown to reduce biomarkers of cardiovascular disease. We aimed to characterize the time course of change in biomarkers of cardiac injury (high‐sensitivity cardiac troponin I), cardiac strain (NT‐proBNP [N‐terminal pro‐B‐type natriuretic peptide]), and inflammation (hs‐CRP [high‐sensitivity C‐reactive protein]) while consuming the DASH diet. Methods and Results The DASH‐Sodium trial was a randomized controlled trial of 412 adults with elevated blood pressure or hypertension. Participants were randomly assigned to 12 weeks of the DASH diet or a typical American diet. Energy intake was adjusted to maintain body weight. Measurements of high‐sensitivity cardiac troponin I, NT‐proBNP, and hs‐CRP were performed in stored serum specimens, collected at baseline and ≈4, 8, and 12 weeks after randomization. In both the control diet and DASH diet, levels of NT‐proBNP decreased; however, there was no difference between diets ( P ‐trend compared with control=0.22). On the DASH diet versus control, levels of high‐sensitivity cardiac troponin I decreased progressively during follow‐up ( P‐ trend compared with control=0.025), but a statistically significant between‐diet difference in change from baseline levels was not observed until week 12 (% difference, 17.78% [95% CI, −29.51% to −4.09%]). A similar pattern was evident for hs‐CRP ( P‐ trend compared with control=0.01; % difference at week 12, 19.97% [95% CI, −31.94% to −5.89%]).

Conclusions

In comparison with a typical American diet, the DASH diet reduced high‐sensitivity cardiac troponin I and hs‐CRP progressively over 12 weeks. These results suggest that the DASH diet has cumulative benefits over time on biomarkers of subclinical cardiac injury and inflammation. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00000608.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary Approaches To Stop HypertensionHypertensionAdultHumansC-Reactive ProteinSodiumTroponin IDietBiomarkersInflammationNatriuretic Peptide, BrainPeptide FragmentsTroponin T

Stichwörter der Autor:innen

Dietary Approaches to Stop Hypertension dietNT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide)biomarkershigh‐sensitivity troponinhs‐CRP (high‐sensitivity C‐reactive protein)

Substanzen

C-Reactive ProteinSodiumTroponin IBiomarkersNatriuretic Peptide, BrainPeptide FragmentsTroponin T

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine Johns Hopkins Medical Institutions Baltimore MD.
  • Division of Cardiology University of Massachusetts Chan Medical School Worcester MA.
  • Beth Israel Deaconess Medical Center Harvard Medical School Boston MA.
  • Harvard T.H. Chan School of Public Health, Harvard Medical School Brigham and Women's Hospital Boston MA.
  • The Johns Hopkins University School of Medicine The Johns Hopkins Bloomberg School of Public Health, and The Welch Center for Prevention, Epidemiology and Clinical Research Baltimore MD.
  • Department of Pathology University of Maryland School of Medicine Baltimore MD.

ORCID-Profile: Matthew J Belanger, Lara C Kovell, Ruth-Alma Turkson-Ocran, Kenneth J Mukamal, Xiaoran Liu, Lawrence J Appel, Edgar R Miller, Frank M Sacks, Robert H Christenson, Alex R Chang, Stephen P Juraschek

Förderung

  • NHLBI NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Belanger, M. J., Kovell, L. C., Turkson-Ocran, R. A., Mukamal, K. J., Liu, X., Appel, L. J., Miller, E. R., Sacks, F. M., Christenson, R. H., Rebuck, H., Chang, A. R., & Juraschek, S. P. (2023). Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial. Journal of the American Heart Association, 12(2). https://doi.org/10.1161/jaha.122.026684

Vancouver

Belanger MJ, Kovell LC, Turkson-Ocran RA, Mukamal KJ, Liu X, Appel LJ, et al. Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial. Journal of the American Heart Association. 2023;12(2). doi:10.1161/jaha.122.026684

BibTeX
@article{Belanger2023,
  author = {Belanger, Matthew J and Kovell, Lara C and Turkson-Ocran, Ruth-Alma and Mukamal, Kenneth J and Liu, Xiaoran and Appel, Lawrence J and Miller, Edgar R and Sacks, Frank M and Christenson, Robert H and Rebuck, Heather and Chang, Alex R and Juraschek, Stephen P},
  title = {Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {2},
  doi = {10.1161/jaha.122.026684}
}
Kostenlos starten →